Serafin Andrew has filed 15 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 2600 shares of Harmony Biosciences Holdings, Inc. ($HRMY) on January 25, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 25, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Restricted Stock Units | 2600 | $0.00 | 7,800.0000 | 58,544,570 | 25.00% | 0.00% |
| Jan. 24, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Common Stock | 2500 | $0.00 | 2,500.0000 | 58,544,570 | 9999.99% | 0.00% |
| Jan. 24, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | F | Common Stock | 1116 | $36.82 | 1,384.0000 | 58,544,570 | 44.64% | 0.00% |
| Jan. 25, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Common Stock | 2600 | $0.00 | 2,600.0000 | 58,544,570 | 9999.99% | 0.00% |
| Jan. 25, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | F | Common Stock | 1126 | $36.82 | 1,474.0000 | 58,544,570 | 43.31% | 0.00% |
| Jan. 22, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Stock Option | 42600 | $0.00 | 42,600.0000 | 58,544,570 | 9999.99% | 0.07% |
| Jan. 22, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Restricted Stock Units | 12200 | $0.00 | 12,200.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 24, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Restricted Stock Units | 2500 | $0.00 | 5,000.0000 | 58,544,570 | 33.33% | 0.00% |
| Jan. 25, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Restricted Stock Units | 10400 | $0.00 | 10,400.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 24, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Restricted Stock Units | 2500 | $0.00 | 7,500.0000 | 57,869,915 | 25.00% | 0.00% |
| Jan. 25, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Stock Option | 36500 | $0.00 | 36,500.0000 | 57,869,915 | 9999.99% | 0.06% |
| Jan. 24, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | F | Common Stock | 865 | $38.01 | 1,635.0000 | 57,869,915 | 34.60% | 0.00% |
| Jan. 24, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Common Stock | 2500 | $0.00 | 2,500.0000 | 57,869,915 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Restricted Stock Unit | 10000 | $0.00 | 10,000.0000 | 60,372,397 | 9999.99% | 0.02% |
| Jan. 24, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Stock Option | 47750 | $0.00 | 47,750.0000 | 60,372,397 | 9999.99% | 0.08% |